Neuphoria Therapeutics Inc. (NEUP)

Neuphoria Therapeutics Statistics

Total Valuation

NEUP has a market cap or net worth of $10.89 million. The enterprise value is -$2.70 million.

Market Cap	10.89M
Enterprise Value	-2.70M

Important Dates

The next estimated earnings date is Saturday, November 15, 2025, before market open.

Earnings Date	Nov 15, 2025
Ex-Dividend Date	n/a

Share Statistics

NEUP has 2.36 million shares outstanding. The number of shares has increased by 95.06% in one year.

Current Share Class	2.36M
Shares Outstanding	2.36M
Shares Change (YoY)	+95.06%
Shares Change (QoQ)	+10.61%
Owned by Insiders (%)	7.81%
Owned by Institutions (%)	46.24%
Float	1.14M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.49
Forward PS	n/a
PB Ratio	0.49
P/TBV Ratio	2.04
P/FCF Ratio	147.14
P/OCF Ratio	147.14
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.56, with a Debt / Equity ratio of 0.01.

Current Ratio	3.56
Quick Ratio	3.37
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	1.93
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -2.03% and return on invested capital (ROIC) is -2.81%.

Return on Equity (ROE)	-2.03%
Return on Assets (ROA)	-1.84%
Return on Invested Capital (ROIC)	-2.81%
Return on Capital Employed (ROCE)	-3.40%
Revenue Per Employee	$1.96M
Profits Per Employee	-$46,204
Employee Count	8
Asset Turnover	0.56
Inventory Turnover	n/a

Taxes

Income Tax	-468,366
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	11.90
200-Day Moving Average	7.41
Relative Strength Index (RSI)	32.87
Average Volume (20 Days)	4,651,481

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, NEUP had revenue of $15.65 million and -$369,632 in losses. Loss per share was -$0.23.

Revenue	15.65M
Gross Profit	15.65M
Operating Income	-829,186
Pretax Income	-837,998
Net Income	-369,632
EBITDA	-166,296
EBIT	-829,186
Loss Per Share	-$0.23

Balance Sheet

The company has $14.21 million in cash and $149,064 in debt, giving a net cash position of $14.06 million or $5.96 per share.

Cash & Cash Equivalents	14.21M
Total Debt	149,064
Net Cash	14.06M
Net Cash Per Share	$5.96
Equity (Book Value)	19.00M
Book Value Per Share	9.60
Working Capital	10.82M

Cash Flow

Operating Cash Flow	77,229
Capital Expenditures	n/a
Free Cash Flow	77,229
FCF Per Share	$0.03

Margins

Gross margin is 100.00%, with operating and profit margins of -5.30% and -2.36%.

Gross Margin	100.00%
Operating Margin	-5.30%
Pretax Margin	-5.35%
Profit Margin	-2.36%
EBITDA Margin	-1.06%
EBIT Margin	-5.30%
FCF Margin	0.49%

Dividends & Yields

NEUP does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-95.06%
Shareholder Yield	-95.06%
Earnings Yield	-3.25%
FCF Yield	0.68%

Analyst Forecast

The average price target for NEUP is $28.00, which is 506.06% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$28.00
Price Target Difference	506.06%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

NEUP has an Altman Z-Score of -7.25 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-7.25
Piotroski F-Score	3